Skip to main content

Together we are beating cancer

Donate now

Research policy

Showing 12 out of 105 results
A picture of Westminster across the Thames on a sunny day

The OECD has published a report looking into the economic impacts of cancer around the world. We believe it can be a powerful tool for change. It shows how focusing on cancer can help drive the UK’s economic growth - and, crucially, it records the cost of doing nothing. The OECD has published a report looking into the economic impacts of cancer around the world. We believe it can be a powerful tool for change. It shows how focusing on cancer can help drive the UK’s economic growth - and, crucially, it records the cost of doing nothing.

by Annalisa Belloni | Analysis | 21 November 2024

21 November 2024

A graphic showing analysis from a genomic test.
  • Health & Medicine
  • Policy & Insight
  • Science & Technology

The story of genomics - and our plan for its next chapter

Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK. Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK.

by Emily Eagles, Tim Gunn | In depth | 7 November 2024

7 November 2024

A picture of Westminster across the Thames on a sunny day

Today was the first budget from the new Chancellor, Rachel Reeves. Here, we take a look at what the autumn statement means for cancer. Today was the first budget from the new Chancellor, Rachel Reeves. Here, we take a look at what the autumn statement means for cancer.

by Ian Caleb | Analysis | 31 October 2024

31 October 2024

scientists in a lab

We've joined the Campaign for Science and Engineering (CaSE), and others in the R&D sector, in writing to the Chancellor urging the UK Government to back R&D if it wants to achieve its ambitions for economic and social growth.  We've joined the Campaign for Science and Engineering (CaSE), and others in the R&D sector, in writing to the Chancellor urging the UK Government to back R&D if it wants to achieve its ambitions for economic and social growth. 

by Amy Warnock | News | 18 October 2024

18 October 2024

Our policy and public affairs team speak to Wes Streeting at the Labour party conference

Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer. Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer.

by Ian Caleb | Opinion | 4 October 2024

4 October 2024

A transparent microplate, made up of small test tubes, over a screen showing a DNA profile.

NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer. NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer.

by Ben Jones | In depth | 8 August 2024

8 August 2024

Cancer Research UK scientists working in a lab at the Francis Crick Institute

With annual visa costs for our institutes projected to rise by 44% this year, we’re calling on the new UK Government to reverse the increases and focus on attracting the world-leading scientists we need to deliver life saving, economy-boosting research. With annual visa costs for our institutes projected to rise by 44% this year, we’re calling on the new UK Government to reverse the increases and focus on attracting the world-leading scientists we need to deliver life saving, economy-boosting research.

by Emma Cattermole | Analysis | 25 July 2024

25 July 2024

This entry is part 2 of 2 in the series International researchers
Chancellor of the Exchequer Jeremy Hunt leaves 11 Downing Street, London, with his ministerial box before delivering his Budget in the Houses of Parliament

We've waded through the wealth of announcements and numbers in yesterday's budget to summarise some of the key points for what this budget means for our mission to beat cancer. We've waded through the wealth of announcements and numbers in yesterday's budget to summarise some of the key points for what this budget means for our mission to beat cancer.

by Ian Caleb | Analysis | 7 March 2024

7 March 2024

A scientist carrying out clinical research in the lab.

Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS. Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS.

by Joe Kiely | Opinion | 12 February 2024

12 February 2024

Two cancer researchers looking at a cell image on screen

Michelle Mitchell, our chief executive, reacts to Labour’s Life Science Plan and explains why science policy will be so important for the UK's future. Michelle Mitchell, our chief executive, reacts to Labour’s Life Science Plan and explains why science policy will be so important for the UK's future.

by Michelle Mitchell | Opinion | 30 January 2024

30 January 2024

This entry is part 1 of 2 in the series International researchers